Therapeutic management of brain metastasis

Lancet Neurol. 2005 May;4(5):289-98. doi: 10.1016/S1474-4422(05)70072-7.

Abstract

This review focuses on the management of brain metastases. The four main modes of therapy are discussed: whole brain radiation therapy (WBRT), surgery, radiosurgery, and chemotherapy. Young patients with limited extracranial disease may benefit from surgical resection of a single brain metastasis, and from radiosurgery (or stereotactic radiotherapy) if two to four brain metastases are present. Whether WBRT after surgery or radiosurgery is beneficial is uncertain. Therefore, two approaches can be justified in patients with a good prognosis: WBRT after surgery or radiosurgery, or alternatively, observation with MRI follow-up after surgery or radiosurgery. A hyperfractionated radiation scheme is then to be preferred to limit late toxicity of WBRT. Patients with extensive extracranial tumour activity or impaired quality of life may benefit from radiosurgery (one to four brain metastases), or from shorter WBRT schedules. We propose a decision tree on the various ways to treat brain metastasis.

Publication types

  • Review

MeSH terms

  • Antineoplastic Protocols / standards*
  • Brain Neoplasms / secondary*
  • Brain Neoplasms / therapy*
  • Combined Modality Therapy / standards
  • Decision Trees
  • Disease Progression
  • Drug Therapy / standards
  • Humans
  • Neoplasm Metastasis
  • Neurosurgical Procedures / standards
  • Prognosis
  • Radiosurgery / standards
  • Radiotherapy / standards